JNJ

Pharmacyclics Shares Plunged: What You Need to Know
Motley Fool
Sat, 12/10/11 - 12:47 pm
Pharmacyclics
JNJ
FDA finds quality lapses, other serious problems in factory for unavailable J&J cancer drug
Yahoo/AP
Fri, 12/9/11 - 09:40 am
FDA
JNJ
Doxil
J&J to Pay Pharmacyclics as Much as $975 Million in Cancer Deal
Bloomberg
Fri, 12/9/11 - 09:39 am
JNJ
Pharmacyclics
PCI-32765
non-Hodgkin's lymphoma
J&J’s Birth-Control Patch Needs More Research on Blood-Clot Risk
Bloomberg
Wed, 12/7/11 - 10:58 am
JNJ
birth control patch
blood clots
Ortho Evra
Affymax Jumps Most in 16 Months on FDA Review of Anemia Drug
Bloomberg
Mon, 12/5/11 - 01:34 pm
Affymax
FDA
anemia
chronic kidney disease
JNJ
Amgen
peginesatide
Drugmakers target hepatitis C
Yahoo/Investor's Business Daily
Sat, 12/3/11 - 03:57 pm
Tibotec
Bristol-Myers Squibb
JNJ
hepatitis C
TMC435
declatasvir. Ribavirin
interferon
Bristol-Myers and J&J will study a combination of 2 of their hepatitis C drug candidates
Yahoo/AP
Fri, 12/2/11 - 12:04 pm
Bristol-Myers Squibb
JNJ
hepatitis C
daclatasvir
TMC435
Something to Watch With Johnson & Johnson
Motley Fool
Thu, 12/1/11 - 05:08 pm
JNJ
Why Large Cap Healthcare Multiples Should Expand
Seeking Alpha
Thu, 12/1/11 - 12:10 pm
Abbott Laboratories
Gilead
JNJ
Merck
Medtronic
Medicis
Pfizer
Gilead's Pharmasset Purchase Could Help Double Market Cap By 2020
Seeking Alpha
Mon, 11/28/11 - 11:38 am
Gilead
Pharmasset
M&A
hepatitis C
GSK
JNJ
Bristol-Myers Squibb
PSI-7977
Vertex
HIV
Vertex: competition fears hit hard
FT.com
Mon, 11/28/11 - 09:53 am
Incivek
Merck
JNJ
Vertex
Four former Synthes execs could get prison terms
Bizjournals.com
Mon, 11/21/11 - 09:39 am
Synthes
Norian
JNJ
Does Johnson & Johnson Pass Buffett's Test?
Motley Fool
Sun, 11/20/11 - 12:13 pm
JNJ
Warren Buffett
Johnson & Johnson Passes This Key Test
Motley Fool
Sat, 11/19/11 - 12:35 pm
JNJ
Dendreon: New Trial To Examine Understatement Of Provenge Life-Extension Benefits
Seeking Alpha
Fri, 11/18/11 - 11:37 am
Dendreon
Provenge
JNJ
prostate cancer
1 Reason Johnson & Johnson's Earnings Aren't So Hot
Motley Fool
Thu, 11/17/11 - 12:53 pm
JNJ
earnings
Meda Agrees to Buy Three Drugs From J&J for $110.5 Million
Bloomberg
Thu, 11/17/11 - 09:00 am
Meda
JNJ
OTC
J&J starts removing toxins from baby products
Yahoo/AP
Wed, 11/16/11 - 05:21 pm
JNJ
Gilead and J&J expand HIV cocktail partnership
Yahoo/AP
Wed, 11/16/11 - 09:51 am
Gilead
JNJ
HIV
Tibotec
Prezista
Emtriva
cobicistat
GS 7340
Doctors reserve judgement on new blood clot drugs
Reuters
Tue, 11/15/11 - 12:36 pm
physicians
bloodthinners
Apixaban
Xarelto
Pradaxa
Bayer
Boehringer Ingelheim
JNJ
Pfizer
Bristol-Myers Squibb

Pages